Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 21 April 2009, doi:10.1136/bmj.b1612
Cite this as: BMJ 2009;338:b1612
| The first 150 words of the full text of this article appear below. |
In a rapid response Leo and Lacasse critiqued a study published in JAMA for not mentioning that a psychosocial intervention was as effective as an antidepressant for post-stroke depression and for failing to record relevant conflicts of interest.1 JAMAs editors have since contacted Leo and his superiors.2 This dispute highlights the fact some studies in respected journals amount to stealth advertising,3 and when legitimate scientific critics point this out, they may be the recipients of academic stalking.4
Stealth advertising and academic stalking mean that many patient volunteers generate research data that are never made accessible to the public. For example, the Turner et al analysis of antidepressant trials found that 3449 depressed patients participated in studies that were never published.5 Another 1843 patients participated in studies in which the data were published as positive in conflict with the Food and Drug Administrations assessment that they were negative studies. Someone
David Antonuccio, professor1, David Healy, professor2
1 Psychiatry and Behavioral Sciences, University of Nevada School of Medicine, Reno, NV 89503, USA, 2 North Wales Department of Psychological Medicine, Cardiff University, Wales LL57 2PW
dantonuccio@medicine.nevada.edu